Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast - 2017 - Research and Markets

Date : 04/21/2017 @ 7:40AM
Source : Business Wire

Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast - 2017 - Research and Markets

Research and Markets has announced the addition of the "Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering.

Introducing the new research, Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast - 2017.

Find out the sales of Glibenclamide / Metformin worldwide and by countries in North America, Europe, Japan, BRIC, and Australia. Discover the growth trends of Glibenclamide / Metformin by countries, and also find out sales forecast until 2021.

The research also provides Glibenclamide / Metformin unit price by countries. The sales and price data from this report is useful for analyzing Glibenclamide / Metformin sales trends, sales forecast for Glibenclamide / Metformin, brand planning, Glibenclamide / Metformin generics trends, product positioning, strategic forecasts, BD&L, competitive intelligence, pricing analysis, and price benchmarks.

Research Scope:

  • Product: Glibenclamide / Metformin
  • Country Scope: US, Germany, France, Italy, Spain, UK, Japan, Brazil, Russia, India, China, Canada, and Australia
  • Companies marketing Glibenclamide / Metformin and by brand name in major countries
  • Historic Glibenclamide / Metformin sales revenues ($mn) worldwide and by countries, sales trends
  • Glibenclamide / Metformin unit price by countries, trends, and benchmarks
  • Glibenclamide / Metformin sales forecast ($mn) worldwide and by countries

Benefits to the User

  • Identify companies marketing Glibenclamide / Metformin by major countries
  • Find out Glibenclamide / Metformin sales, growth, and sales forecast by major countries; Use it for your market planning - market assessments, market sizing, market shares, BD&L, product strategy, positioning, and competitive intelligence
  • Determine the price of Glibenclamide / Metformin in major markets; Use it to devise pricing strategies, estimate patient shares, develop patient forecast models, and estimate annual therapy costs
  • Derive unit sales of Glibenclamide / Metformin by countries using pricing and sales data; Use it for your market planning - market assessments, market sizing, market shares, BD&L, product strategy, positioning, and competitive intelligence

Key Topics Covered:

1. Glibenclamide / Metformin - Introduction

2. Glibenclamide / Metformin Sales Analysis

3. Glibenclamide / Metformin Sales by Countries

4. Glibenclamide / Metformin Price Analysis by Countries

5. Glibenclamide / Metformin Sales Forecast

6. Glibenclamide / Metformin Sales Forecast by Countries

7. Methodology

For more information about this report visit http://www.researchandmarkets.com/research/nnc9tl/glibenclamide

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Related Topics: Endocrine and Metabolic Disorders Drugs, Drugs by Therapeutic Area

Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20170819 03:24:29